Study of Fluoxetine in Patients With Depersonalization Disorder
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to:
1) Determine the effects of fluoxetine in the treatment of depersonalization disorder, 2)
Assess the durability of treatment response in these patients, 3) Assess the improvement in
psychiatric disability in these patients, and 4) Assess the effects of comorbid Axis I
disorders (depression, social phobia, panic/anxiety, obsessive-compulsive disorder) and Axis
II personality disorders on treatment outcome in these patients.